Henry Schein, Inc. (NASDAQ:HSIC – Free Report) – Investment analysts at William Blair decreased their Q3 2024 earnings estimates for shares of Henry Schein in a report issued on Tuesday, August 6th. William Blair analyst B. Vazquez now forecasts that the company will earn $1.16 per share for the quarter, down from their prior estimate of $1.32. The consensus estimate for Henry Schein’s current full-year earnings is $5.16 per share. William Blair also issued estimates for Henry Schein’s Q4 2024 earnings at $1.25 EPS, FY2024 earnings at $4.74 EPS, Q1 2025 earnings at $1.26 EPS, Q2 2025 earnings at $1.30 EPS, Q3 2025 earnings at $1.43 EPS, Q4 2025 earnings at $1.48 EPS and FY2025 earnings at $5.13 EPS.
Henry Schein (NASDAQ:HSIC – Get Free Report) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.01. The business had revenue of $3.10 billion for the quarter, compared to the consensus estimate of $3.27 billion. Henry Schein had a net margin of 3.12% and a return on equity of 13.51%. Henry Schein’s revenue for the quarter was up .0% on a year-over-year basis. During the same period last year, the company posted $1.31 EPS.
View Our Latest Analysis on HSIC
Henry Schein Stock Up 1.1 %
NASDAQ HSIC traded up $0.78 during trading hours on Thursday, reaching $68.94. 2,399,686 shares of the company’s stock were exchanged, compared to its average volume of 1,227,769. The company’s 50-day moving average is $67.73 and its two-hundred day moving average is $71.57. Henry Schein has a one year low of $60.01 and a one year high of $82.63. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.02 and a current ratio of 1.75. The company has a market capitalization of $8.83 billion, a price-to-earnings ratio of 23.29, a price-to-earnings-growth ratio of 1.80 and a beta of 0.87.
Institutional Investors Weigh In On Henry Schein
Large investors have recently made changes to their positions in the stock. Summit Securities Group LLC acquired a new stake in Henry Schein during the 2nd quarter valued at $31,000. Beach Investment Counsel Inc. PA acquired a new stake in Henry Schein during the 2nd quarter valued at $37,000. Blue Trust Inc. lifted its holdings in Henry Schein by 104.2% during the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after purchasing an additional 475 shares during the last quarter. Mather Group LLC. acquired a new stake in Henry Schein during the 1st quarter valued at $97,000. Finally, Palisade Asset Management LLC acquired a new stake in Henry Schein during the 1st quarter valued at $113,000. Institutional investors and hedge funds own 96.62% of the company’s stock.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Recommended Stories
- Five stocks we like better than Henry Schein
- What Are the FAANG Stocks and Are They Good Investments?
- Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?
- Canadian Penny Stocks: Can They Make You Rich?
- MarketBeat Week in Review – 8/5 – 8/9
- Conference Calls and Individual Investors
- The Cannabis Sector: Profitability Takes Center Stage
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.